Categories: BioTechHealthTechMedtech
Clinical stage biotechnology company dedicated to advancing the treatment of a range of immunological conditions
Investors 2
Mentions in press and media 4
| Date | Title | Description |
| 08.01.2025 | WuXi Biologics: Pioneering the Future of Biologics and Sustainability | In the bustling world of biotechnology, WuXi Biologics stands tall like a lighthouse guiding ships through foggy waters. This global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) is not just a player; it’s... |
| 07.01.2025 | WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager | SHANGHAI and SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced an agreement with Candid Therape... |
| 09.09.2024 | Candid Therapeutics Raises $370M in Funding | Candid Therapeutics, a San Diego, CA-based biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, raised $370M in funding.
The round was co-led by Venrock Healthcare Capital Partners, ... |
| - | Candid Therapeutics | “Home - Candid Therapeutics” |
Reviews 0
